Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:latanoprost
gptkb:netarsudil |
| gptkbp:approvalYear |
2019
|
| gptkbp:ATCCode |
S01EE51
|
| gptkbp:combinationTherapy |
yes
|
| gptkbp:form |
eye drops
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rocklatan
|
| gptkbp:latanoprostClass |
prostaglandin analogue
|
| gptkbp:manufacturer |
gptkb:Aerie_Pharmaceuticals
|
| gptkbp:marketedAs |
gptkb:Alcon
|
| gptkbp:mechanismOfAction |
reduces intraocular pressure by increasing outflow of aqueous humor
|
| gptkbp:netarsudilClass |
Rho kinase inhibitor
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
ophthalmic
|
| gptkbp:sideEffect |
eye irritation
conjunctival hyperemia increased pigmentation of iris |
| gptkbp:usedFor |
ocular hypertension
open-angle glaucoma treatment of elevated intraocular pressure |
| gptkbp:bfsParent |
gptkb:Aerie_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|